Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patient case studies.

P Kopelman1

  • 1St Bartholomew's and The Royal London Hospital School of Medicine and Dentistry, Queen Mary and Westfield College, University of London, London, UK. pgkopelman@mds.qmw.ac.uk

International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|August 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Executive summary: Foresight 'Tackling Obesities: Future Choices' project.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2007
Same author

Health risks associated with overweight and obesity.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2007
Same author

Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.

International journal of obesity (2005)·2006
Same author

Dietary advice for treatment of type 2 diabetes mellitus in adults.

The Cochrane database of systematic reviews·2004
Same author

Dietary advice for treatment of type 2 diabetes mellitus in adults.

The Cochrane database of systematic reviews·2004
Same author

Energy metabolism in Bardet-Biedl syndrome.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2003
Same journal

Lipotoxicity: the obese and endurance-trained paradox.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2004
Same journal

Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2004
Same journal

Fat storage in pancreas and in insulin-sensitive tissues in pathogenesis of type 2 diabetes.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2004
Same journal

Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2004
Same journal

Role of energy charge and AMP-activated protein kinase in adipocytes in the control of body fat stores.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2004
Same journal

Concept of fat balance in human obesity revisited with particular reference to de novo lipogenesis.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2004
See all related articles

Managing obese patients with type 2 diabetes presents challenges. This case series highlights dilemmas in initiating oral agents, insulin therapy, and managing the metabolic spiral, emphasizing cardiovascular risk and pharmacotherapy options.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Clinical Medicine

Background:

  • Obesity and type 2 diabetes mellitus (T2DM) are significant global health concerns.
  • Effective management of T2DM in obese individuals is complex and presents clinical challenges.
  • Cardiovascular risk is substantially elevated in this patient population.

Observation:

  • Presents three distinct cases of obese patients with T2DM.
  • Case 1: Timing of oral hypoglycaemic agent initiation in asymptomatic, newly diagnosed patients.
  • Case 2: Insulin initiation criteria amidst weight gain and poor glycaemic control.
  • Case 3: Illustrates the progressive metabolic deterioration, weight gain, and co-morbidities.

Findings:

  • Highlights clinical decision-making difficulties in pharmacotherapy for obese T2DM patients.

Related Experiment Videos

  • Demonstrates the challenges in managing glycaemic control and weight simultaneously.
  • Identifies the 'vicious metabolic spiral' common in this demographic.

    • Implications:

    • Provides insights into managing complex T2DM cases in obese individuals.
    • Discusses the critical cardiovascular risks associated with obesity and T2DM.
    • Suggests potential management strategies, including adjunctive anti-obesity pharmacotherapy.